1. Home
  2. PRTC vs IIIV Comparison

PRTC vs IIIV Comparison

Compare PRTC & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • IIIV
  • Stock Information
  • Founded
  • PRTC 2015
  • IIIV 2012
  • Country
  • PRTC United States
  • IIIV United States
  • Employees
  • PRTC 90
  • IIIV N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • IIIV EDP Services
  • Sector
  • PRTC Health Care
  • IIIV Technology
  • Exchange
  • PRTC Nasdaq
  • IIIV Nasdaq
  • Market Cap
  • PRTC 504.9M
  • IIIV 537.1M
  • IPO Year
  • PRTC N/A
  • IIIV 2018
  • Fundamental
  • Price
  • PRTC $20.80
  • IIIV $25.24
  • Analyst Decision
  • PRTC Buy
  • IIIV Buy
  • Analyst Count
  • PRTC 1
  • IIIV 7
  • Target Price
  • PRTC $45.00
  • IIIV $27.14
  • AVG Volume (30 Days)
  • PRTC 3.4K
  • IIIV 150.6K
  • Earning Date
  • PRTC 08-28-2024
  • IIIV 11-13-2024
  • Dividend Yield
  • PRTC N/A
  • IIIV N/A
  • EPS Growth
  • PRTC N/A
  • IIIV N/A
  • EPS
  • PRTC N/A
  • IIIV N/A
  • Revenue
  • PRTC $468,000.00
  • IIIV $371,160,000.00
  • Revenue This Year
  • PRTC N/A
  • IIIV N/A
  • Revenue Next Year
  • PRTC $139.60
  • IIIV $1.85
  • P/E Ratio
  • PRTC N/A
  • IIIV N/A
  • Revenue Growth
  • PRTC N/A
  • IIIV 46.48
  • 52 Week Low
  • PRTC $17.08
  • IIIV $17.54
  • 52 Week High
  • PRTC $34.00
  • IIIV $25.54
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 55.95
  • IIIV 73.65
  • Support Level
  • PRTC $20.35
  • IIIV $22.89
  • Resistance Level
  • PRTC $20.95
  • IIIV $25.54
  • Average True Range (ATR)
  • PRTC 0.62
  • IIIV 0.46
  • MACD
  • PRTC 0.10
  • IIIV 0.18
  • Stochastic Oscillator
  • PRTC 75.51
  • IIIV 82.25

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About IIIV i3 Verticals Inc.

i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Merchant Services and Software and Services. The company generates maximum revenue from the Software and Services segment. The company's strategic vertical market includes schools, the public sector, not-for-profit organizations, healthcare and others. It provides various solutions such as, gateway, payment processing, online payment, Document management, and ERP among others.

Share on Social Networks: